Navigation path
Combating deadly diseases, EU funding FP6 projects
Coordinators list
List of project (sorted by Coordinator)
| AABY Peter | BCGNSE BCG Vaccination and Childhood Morbidity and Mortality: Interventions with Possible Implications for Immunisation Policy in Developing Countries |
| AARØ Leif Edvard | SATZ Promoting Sexual and Reproductive Health. School-Based HIV/AIDS Prevention in Sub-Saharan Africa |
| ALONSO Pedro L. | Malaria Age Exposure Age of Exposure and Immunity to Malaria in Infants |
| Andrew Waters | Evimalar Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (Evimalar). |
| ARNOT David | EUROMALVAC1 A European Malaria Vaccine Development Consortium EUROMALVAC-2 The Second Phase of a European Malaria Vaccine Development Consortium |
| AUTRAN Brigitte | THERAVAC Evaluation of a Therapeutic Vaccination Strategy for HIV-1 Infection TheraVac |
| BALZARINI Jan | HIV RESISTANCE New Tools to Investigate and Suppress HIV Drug Resistance |
| Behazine COMBADIERE | CUT’HIVAC Cutaneous and Mucosal HIV Vaccination |
| BARNETT D | Teach CD4 International CD4 T-Lymphocyte Training Programme for the Support of HIV Clinical Trials Networks |
| BEITZ Eric | MalariaPorin Validation of the Plasmodium Aquaglyceroporin as a Drug Target |
| BENKIRANE Monsef | HIDDEN HIV CHALLENGE Challenging the Hidden HIV: Understanding the Block on Transcriptional Reactivation to Eradicate Infection |
| BERNEY Helen | DISSARM Development of Integrable Sensors for Screening of Antibiotic Resistance in Mycobacterium |
| BOELAERT Marleen | PARASAC Organisation of an International Conference: Moving targets - Parasites, Resistance and Access to Drugs from 4-6 December 2000 |
| BÖTTGER Erik C. | TB prevention cluster New Strategies for Treatment and Prevention of Mycobacterial Diseases CSI LTB The role of chromosome stability in persistence, latency and reactivation of Mycobacterium tuberculosis |
| BOUCHER Charles AB | EuropeHIVResistance European Cohort Coordinating Network on HIV Drug Resistance UNITE-MORE Uniformity in Testing and Monitoring HIV Resistance |
| BOUCHER Charles and WENSING Annemarie |
SPREAD Strategy to Control SPREAD of HIV Drug Resistance |
| BRABIN Bernard | PREMA-EU A Cost-Shared Concerted Action on Malaria and Anaemia Control in Pregnant Women |
| BUV Anne | ORISS Project Operational Research in STI and Related Services for Women in High-Risk Situations in Cambodia and Thailand |
| Charles Kelly | CHAARM Combined Highly Active Anti-retroviral Microbicides |
| CHIMINI Giovana | MPCM
Pathogenic Role of MicroParticles in Cerebral Malaria |
| Cirillo Daniela M. | TB PAN-NET TB PAN-NET: Pan-European network for study and clinical management of drug resistant tuberculosis. TM-REST TM-REST: a new platform for fast molecular detection of MDR and XDR resistant strains of M. tuberculosis and of drug resistant malaria |
| COLE Stewart T. | NM4TB New Medicines for Tuberculosis X-TB Structural and Functional Genomics of Mycobacterium Tuberculosis |
| COOSEMANS Marc | MALVECASIA Monitoring Insecticide Resistance and Mapping Malaria Vectors in Southeast Asia : A Prerequisite for Sustainable Malaria Vector Control |
| CUTTING Simon M. | INNOVAC Highly Innovative Strategies for Vaccination to Poverty Related Diseases |
| DALESSANDRO Umberto | LAMNET New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa |
| DARBYSHIRE Janet | CASCADE Concerted Action on SeroConversion to AIDS and Death in Europe |
| DEGETT Jens | EAGLES European Action in Global Life Sciences - Health Programme |
| DO ROSRIO Virglio E. | RESMALCHIP Development of a Malaria-Resistant DNA Chip as a Public Health Tool for the Management of Plasmodium Falciparum Malaria Drug Resistance |
| DOERIG Christian | SIGMAL Targeting Malaria Transmission Through Interference with Signalling in Plasmodium falciparum Gametocytogenesis |
| DRUILHE Pierre | EMLI Phase-I and II Trials of the Malaria Pre-Erythrocytic Vaccine LSA-3 and Refinement of Measurable Outcomes |
| DUJARDIN Bruno | DOT AFRICAN TRIAL A Multicentre Randomised Trial of Directly Observed Treatment for Tuberculosis Patients in Sub-Saharan Africa |
| ENSOLI Barbara | AVIP Aids Vaccine Integrated Project |
| EUGEN-OLSEN Jesper | TB Treatment Marker Establishing a TB Treatment Efficacy Marker |
| FAXELID Elisabeth | Bridging gaps Bridging the Gaps Between Public and Traditional Healthcare Sectors Testing a Model to Improve Quality of STI/HIV/AIDS Care in sub-Saharan Africa |
| FERRANTELLI Flavia | VIAV Very Innovative AIDS Vaccine |
| FISCHER Rainer | PHARMA-PLANTA Recombinant Pharmaceuticals from Plants for Human Health |
| GARCIA Maria J. | CELL CYCLE & DORMANCY IN TB Regulation of the Cell Cycle and Dormancy in Mycobacterium Tuberculosis |
| GIANQUITO Carlo | PENTA/ECS Paediatric European Network for Treatment of AIDS and European Collaborative Study on HIV-infected pregnant women and their children PENTA Paediatric European Network for the Treatment of AIDS |
| GICQUEL Brigitte | TB VACCINE CLUSTER A Cluster for Tuberculosis Vaccine Development |
| GIJS Martin | DETECTHIV Sensitive Nanoparticle Assay For the Detection of HIV |
| GILBERT Ian | Plasmodium dUTPase Deoxyuridine Triphosphate Nucleotidohydrolase as a Drug Target against Malaria |
| GLÜCK Reinhard | SME Malaria SME Led Malaria Vaccine Initiative |
| GOMES Melba | ARTESUNATE Research and Development of Rectal Artesunate |
| GOUDSMIT Jaap | PRIBOMAL Preclinical Studies towards an Affordable, Safe and Efficacious Two-Component Paediatric Malaria Vaccine |
| GROLMUSZ Vince | scrIN-SILICO Finding Promising Drug Candidates Against Tuberculosis with Multidisciplinary Protocol Based Non-Conventional Search |
| HARTMANN Marcus and BRANDT Remco | CILMALVAC The Tetrahymena system as an innovative approach to malaria antigene expression |
| HOELSCHER Michael | CTL and HIV- super Infection CTL-Mediated Protection from HIV-1 Infection in a High-Risk Cohort in Tanzania: Persistent Seronegativity, Persistent Single-Subtype Infection, and Cross-Subtype Superinfection HIV-superinfections Behavioural, Immunological and Virologic Correlates of HIV-1 Superinfection (HIV+ vs HIV++) in Rural Tanzania |
| HOLMES Harvey | EVA Programme EVA (European Vaccine Against Aids) Centralised Facility For Aids Reagents |
| HUET Jacqueline | MUNANO VAC Mucosal Nano Vaccine Candidate for HIV |
| HUNSMANN Gerhard | ENVEP European Network for Vaccine Evaluation in Primates: Combined Vector Immunisation for AIDS Vaccine Development |
| HVIID Lars | HUMALMAB Human monoclonal antibodies as tools for malaria research and therapy |
| Jelle Thole | NEWTBVAC Discovery and preclinical testing of new vaccine candidates for tuberculosis |
| JEPSEN Soeren | AMVTN/AMANET African Malaria Vaccine Testing Network AMVTNETHIC AMVTN Workshops on the Molecular Biology and Immunology of Malaria Vaccines EMVDA The European Malaria Vaccine Development AssociationThe European Malaria Vaccine Development Association EMVI European Malaria Vaccine Initiative EMVI-TRIAL-PROTOCOLS European Malaria Vaccine Clinical Trial Protocols EURHAVAC European Network for Harmonisation of MalariaVaccine Development NEMLAR AMVTN Seminar on Health Research Ethics in Africa |
| JOMAA Hassan | NEW ANTIMALARIALS Clinical and Pre-Clinical Evaluation of Fosmidomycin and its Derivates as Antimalarial Drugs NEW ANTIMYCOBACTERIALS Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Drugs Against Tuberculosis SENSITIVE TARGETS Oxygen-Sensitive Enzymes of the Mevalonate-Independent Isoprenoid Biosynthesis Pathway as Targets for New Antimalarial and Anti-TB Drugs |
| KAPPES Barbara | VITBIOMAL Vitamin Biosynthesis as a Target for Antimalarial Therapy |
| KELLY Charles | EMPRO European Microbicides project |
| KERI György | TB-DRUG A SME-STREP for Tuberculosis Drug Development |
| KESTENS Luc | TBIRIS Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART |
| KIECHEL Jean-Ren | FACT Development of Oral Fixed Dose Artesunate-Based Combinations for the Treatment of Uncomplicated Malaria |
| KLINKERT Mo | PAMVAC The Development of Vaccine Against Pregnancy-Associated Malaria - PAMVAC (Pregnancy-Associated Malaria Vaccine) |
| KOOPMAN Gerrit | HIV COM THER Development and Testing of a Combined Anti-Retroviral, Immune, and Gene Therapy for Treatment of HIV Patients Pox-gene A Combined Pox-virus/Lentiviral Vector System to Treat HIV Infection; Immunisation and Direct In Vivo Gene Transfer in T-Lymphocytes |
| KREMER Kristin | TBADAPT Effect of Genetic Variation in Mycobacterium Tuberculosis on Vaccine Escape and the Acquisition of Drug Resistance |
| KRAEUSSLICH Hans-Georg | HIV PI resistance HIV protease inhibitor resistance by enzyme- substrate coevolution HIV PR INHIBITORS Rational Approaches Towards Understanding and Overcoming HIV Protease Inhibitor Resistance |
| KULIKOWSKI Tadeusz | HIVResInh Preparation and Identification of New HIV Reverse Transcriptase Inhibitors Targeted Against HIV Strains Resistant to anti-HIV/AIDS drugs |
| LA COLLA Paolo | SHIVA Selection and Development of Microbicides for Mucosal Use to Prevent Sexual HIV Transmission/Acquisition |
| LACEY Charles | no acronym Collaboration on Vaginal Microbicides Development for the Prevention of HIV Transmission |
| LAGA Maria | MICROBICIDES 2002 Conference Microbicides 2002 Antwerp, 12-15 May 2002 |
| LAMBERT Paul-Henri | ADVAC-EC Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty |
| LANZER Michael | ADMALI Adhesive Interactions in Malaria: New Targets for Intervention MALCROSS Genetic Analysis of the Chloroquine Drug Resistance and the Accelerated-Resistance-to Multiple Drugs Phenotypes in the Human Malarial Parasite Plasmodium Falciparum |
| LEHNER Thomas | Allomicrovac A combined microbicidal-immunizing strategy against SIV and HIV infection INNOVAC Highly Innovative Strategies for Vaccination to Poverty Related Diseases |
| LIENHARDT Christian | ACCELTB EU Accelerated Action Against Tuberculosis: The Agenda for Africa AFTBVAC Development of a Tuberculosis Vaccine in Africa OFLOTUB A Multicentre, Randomised, Control Trial of Ofloxacine-Containing, Short-Course Regimen for the Treatment of Pulmonary Tuberculosis |
| LILJESTROM Peter | VaccTIP Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways EUROVAC I European Vaccine Effort Against HIV/AIDS EUROVAC II European Vaccine Effort Against HIV/AIDS-II |
| LUDEWIG Burkhard | AIDS-CoVAC Generation of a Coronavirus-Based Multigene AIDS Vaccine and Evaluation in a Preclinical SIV model |
| LUND Ole | Vaccines4TB Genome- and HLA- Wide Scanning and Validation of Cytotoxic CD8 T Cell Responses against Mycobacterium Tuberculosis |
| LUNDGREN Jens D. | EuroSIDA The EuroSIDA network 2000-200: Clinical and Virological Outcome of European Patients Infected with HIV EuroSIDA 2005-2009 The EuroSIDA Network 2005-2009 Clinical and Virological Outcome of Patients with HIV under Care in Europe |
| LYCKE Nils | ISCOTB Novel Approaches to Induce Mucosal Immunity Against TB Using the Combined Adjuvant Strategy of CTA-1 and ISCOMS |
| MANGANELLI Riccardo | MYCOMANCY Transcriptional Regulation And Cellular Localisation Of Mycobacterial Cell Cycle Proteins During Dormancy |
| Maria Jesus Garcia | StopLATENT-TB “LATENT TUBERCULOSIS: New tools for the detection and clearance of dormant Mycobacterium tuberculosis.” |
| MARSH P. D. | MUCOSAL TB VACCINE Role of Mucosal Immunity for Protection against Tuberculosis |
| NEWELL WITH C.THOME, CS.PECKHAM ML | ECS European Collaborative Study on Pregnant HIV Infected Women and Their Children |
| NISINI Roberto | MILD-TB Immunogenicity of Mycobacterium Tuberculosis lipids in the Non Replicating Status of latency |
| OGGIONI Marco R. | LONG-DRUG Characterisation of Mycobacterium Tuberculosis Populations During Infection: A Longitudinal Study on Drug Resistance Development |
| Olivier Neyrolles | TB-VIR Mycobacterium tuberculosis W-Beijing genetic diversity and differential virulence and immune responses |
| OLSEN Wenche Marie | New cAMP antagonists Development of Antagonists that Disrupt the Hyperactivated cAMP Signalling Pathway in Immunodeficiencies as Immunostimulatory Therapy |
| PANTALEO Giuseppe | EuroVac-III European Vaccine Effort Against HIV/AIDS III |
| PETIT Serge | READ-UP Redox Antimalarial Drug discovery |
| POLI Guido | GISHEAL Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors |
| PORTAELS Françoise | TB-DRUG OLIGOCOLOR Development of a Molecular Platform for the Simultaneous Detection of Mycobacterium tuberculosis Resistance to Rifampicin and Fluoroquinolones Upgrade Diagno MDR-TB Improved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America |
| PORTER Kholoud | CASCADE Concerted Action on SeroConversion to AIDS and Death in Europe CASCADE Virology Virological Characterisation of Primary HIV Infection in the Concerted Action on SeroConversion to AIDS and Death in Europe EuroCoord European network of HIV/AIDS cohort studies to coordinate at European and International level clinical research on HIV/AIDS |
| POURCEL Christine | Tuberculosis China The Diversity of Mycobacterium Tuberculosis Strains in China: Tracing the Origins of the Worldwide Dispersion of the Multidrug-Resistant Beijing Genotype |
| PREISER Peter | VIRIMAL Structure, Function and Vaccine Potential of the Vir Multigene Family in Malaria |
| RACZ P. and KLARA TENNER-RACZ |
DETEC SIV/HIV Vaccines: Detecting Efficacy and Explaining Inefficacy MUVADEN Mucosal Vaccines Against Human and Simian Immunodeficiency Viruses Based on Dendritic Cells |
| RAPPUOLI Rino | MUVAPRED Mucosal Vaccines for Poverty Related Diseases |
| RENIA Laurent | MALINV Differential Expression of Malaria Invasion-Associated Proteins in the porozoite: Novel Vaccination Strategy |
| RIBAS DE POULANA Lluis | MEPHITIS Targetting protein synthesis in the apicoplast and cytoplasm of plasmodium |
| RICCIARDI-CASTAGNOLI Paola | MM-TB Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes |
| ROBIN SHATTOCK | CHAARM Combined Highly Active Anti-retroviral Microbicides |
| Roland Brosch | NOVSEC-TB Novel secretion systems of Mycobacterium tuberculosis and their role in host-pathogen interaction. |
| ROTTENBERG Martin | Neotim Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants |
| S A WARD | AntiMal Development of New Drugs for the Treatment of Malaria |
| SAKSELA Kalle | TARGETING NEF The HIV-1 Pathogenicity Factor Nef as a Novel Therapeutic Target |
| SANDSTROM Eric | HIVIS Study of Immunogenicity of DNA HIV-1 env, gag and pol Plasmid Vaccines Boosted with MVA in Tanzania: HIV Vaccine Immunogenicity Study |
| SANJEEV Krishna | NANOMAL Development of a handheld antimalarial drug resistance diagnostic device using nanowire technology |
| SAUERBORN Rainer | MAMOP Improving the Management of Childhood Malaria: An Experiment to Bridge the Gap Between Mothers and Healthcare Providers |
| SAUERWEIN R.W. | MALTRANS Project Interruption of Malaria Transmission Vaccine Strategies REDMAL Clinical Development of a Pfs48/45-based malaria transmission blocking vaccine |
| SCALA Giuseppe | EPI-VAC Identification of Novel Epitopes as HIV-1 Vaccine Candidates |
| SCARLATTI Gabriella | HIV-1 MTCT International Network on HIV-1 Mother-to-Child Transmission: Developing Integration of Healthcare Programmes, Clinical, Social and Basic Research NeutNet Standardisation of HIV Neutralisation Assays to be Used in Vaccine Research and Clinical Trials |
| SCHERF Artur | BioMalPar Biology and Pathology of the Malaria Parasite |
| SCHUURMAN Rob | VIRULENCE HIV-1 Reverse Transcriptase Inhibitor Resistance and Its Consequences for Viral Virulence |
| SCHWARTZ Olivier | NEWHIVTARGETS Identifying novel classes of HIV inhibitors |
| SHATTOCK Robin | EUROPRISE European Vaccines and Microbicides Enterprise |
| SINGH TMahavir | FASTEST-TB Development and Clinical Evaluation of Fast Tests for Tuberculosis Diagnosis NEWTBDRUGS New Drugs for Persistent Tuberculosis: Exploitation of 3-D Structure of Novel Targets, Lead Optimisation and Functional In-Vivo Evaluation PERSISTENT TB Novel Drug Targets Specific to Persistent (Latent) Tuberculosis Infection: Crystallisation, Structure Determination and Functional Studies |
| SPETZ Anna-Lena | Auto/AlloCell-HIV Development of a Novel Therapeutic HIV-1 Vaccine: Horizontal Gene Transfer by Using Apoptotic HIV-1 DNA Containing Activated T-cells |
| STANESCU Ioana | EPIVAC Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS |
| STEWART Graham | TBMACS Identification and characterisation of Mycobacterium tuberculosis virulence genes involved in macrophage parasitism |
| STIEGLER Gabriela | HIV VIROSOMES Development of a New Vaccine Against HIV: Virosomes Incorporating HIV proteins |
| SUTTER Gerd | MVACTOR Host Immune Activation Optimised Vaccinia Virus Vectors for Vaccine Development |
| SWABURY Alawi | CPN-YAS-PRD Contact Point Network to Attract Young African Scientists to Participate in EU-Funded PRD Research Projects |
| TEMMERMAN Marleen | CASA Optimising the Use of the Syndromic Approach for STI Management and Prevention in Resource Poor Settings |
| THOLE Jelle | TB-VAC TB-VAC: An Integrated Project for New Vaccines against Tuberculosis |
| TOMEI David | TB-trDNA Evaluation of Transrenal-DNA Detection to Diagnose Tuberculosis |
| TREBUCQ Arnaud | COCONUTKIT Project to coordinate the write up of a protocol for a clinical trial aimed at shortening treatment for tuberculosis |
| TRILLA Antoni | EDCTP European and Developing Countries Clinical Trials Programme |
| ÜBERLA Klaus | DEC-VAC Development of a Dendritic Cell-targeted Vaccine against AIDS TIP-VAC Explaining and Improving Efficacy of Targeted Immunodeficiency Virus-like Particle Vaccines against AIDS |
| VAN DER STUYFT Patrick | SN-TB DIAGNOSIS A System Approach to Optimising Diagnosis of Smear-Negative Tuberculosis in High and Low Prevalence Countries of South America |
| VAN DER ZEIJST Bernard A.M. |
Immuno VacTB A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis |
| VAN HOLST Gerrit-Jan | HIVSTOP Development of an Effective RNA Interference-Based Anti-HIV-1 Therapy Using an SV40-Derived Vector |
| VAN SOOLINGEN Dick | Mol.Epidemology TB New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis |
| VIAL Henri | NOVEL ANTIMALARIALS Malarial Chemotherapy Targeting Plasmodial Phospholipid Biosynthesis: Implementation of a Pro-drug Strategy for Orally Active Compounds |
| VON LAER Dorothee | VirApt Antiviral Aptamers for Treatment of HIV-1 Infection |
| VOSS Gerald | HIVPRIMEBOOST THERVAC Improvement of a Therapeutic Adjuvanted Protein HIV Vaccine by Combination with DNA Immunisation in a Prime-Boost Regimen RMVHIV Recombinant Measles Virus as a Vector for HIV Vaccines |
| WATERS Andrew | ATTMAL New Genetic Technologies: Applications to Generate Attenuated Malaria Vaccines |
| WELDINGH Karin | SERO-TB Development of a Specific Serological Kit for the Diagnosis of TB |
| WITVROUW Myriam | ExCellENT-HIT Exploiting Cellular Transport of Nuclear Transcripts as HIV Innovative Therapy TRIoH Targeting Replication and Integration of HIV |
| WOLF Hans | China-HIV-VacIII Phase I/II clinical testing of Clade C-based HIV-1 Candidate Vaccines in China HIVAB Generation of Broadly Cross Neutralising Antibodies for Innovative Active-passive HIV Vaccination Strategies Based on Modified Ig-gene Transgenic Mice |
| YUTHAVONG Yongyuth | PVPFDHFR Dihydrofolate Reductase-Thymidylate Synthase from Plasmodium Vivax and P. falciparum asTargets for Antimalarial Chemotherapy |
| ZUMLA Alimuddin | VACSEL Longitudinal Study of Correlates of Immunity to Tuberculosis in Exposed Individuals VACSIS Host-Parasite Relationship in Susceptibility to Tuberculosis |